PMC:7560808 / 3306-3556 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":148,"end":165},"obj":"Body_part"},{"id":"T14","span":{"begin":160,"end":165},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma66772"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T18","span":{"begin":111,"end":112},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T19","span":{"begin":148,"end":165},"obj":"http://purl.obolibrary.org/obo/CL_0000115"},{"id":"T20","span":{"begin":167,"end":170},"obj":"http://purl.obolibrary.org/obo/CL_0000115"}],"text":"To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":79,"end":90},"obj":"http://purl.obolibrary.org/obo/GO_0009056"}],"text":"To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions."}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":0,"end":250},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions."}

{"project":"LitCovid-PubTator","denotations":[{"id":"110","span":{"begin":38,"end":43},"obj":"Gene"},{"id":"126","span":{"begin":98,"end":101},"obj":"Chemical"},{"id":"127","span":{"begin":220,"end":223},"obj":"Chemical"}],"attributes":[{"id":"A110","pred":"tao:has_database_id","subj":"110","obj":"Gene:60495"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To demonstrate that the deficiency of Hpa-2 is mechanistically involved in the degradation of the eGC, we used a microfluidic chamber with cultured endothelial cells (ECs) under flow that synthesize an intact and stable eGC under in vitro conditions."}